Howard county considers Elkridge to setup drug treatment center
Category: #health  By Pankaj Singh  Date: 2018-04-14
  • share
  • Twitter
  • Facebook
  • LinkedIn

Howard county considers Elkridge to setup drug treatment center

Howard county, a region that made it to the headlines due to its soaring numbers of opioid related fatalities, is expected to witness the construction of its first residential drug treatment center in Elkridge. Reportedly, the possible site is adjacent to the Mayfield Maintenance Facility.

The three bids presented by architectural firms to survey the Mayfield site are being reviewed by Howard county officials to determine if the land is sufficient to house the facility. Whether the three-acre Mayfield site is the right choice will be known after the completion of the survey which is estimated to cost around $100,000. The county has set aside a budget of $250,000 for the project planning and survey.

Speaking on the development, Director of Policy and Programs, Carl DeLorenzo reportedly said that the maintenance facility will be moved to make space for the treatment center. He further stated that once the Mayfield site is chosen to be right, the next major step will be to decide whether the facility should be county owned or privately owned.

As per reliable sources, the decision would be based on the cost comparison of a public vs private owned facility and how quickly it can be built as Howard county urgently needs a drug treatment center.

According to the county police, from the beginning of 2018 till April 9th there had been 77 cases of fatal and non-fatal opioid overdose. The number has climbed when compared to the overdose cases for the same time span in 2017.

The project has been included in the proposed 2019 capital budget by County Executive Allan Kittleman though funds are yet to be allocated to the facility. It is expected to open in 2023 and the project description includes an estimated budget of $14.8 million. However, according to reliable sources, the dates and the budget are dependent on the pace at which the project moves forward.



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

US buys all of the global supply of Gilead’s COVID-19 drug remdesivir
US buys all of the global supply of Gilead’s COVID-19 drug remdesivir
By Pankaj Singh

While top-notch companies are racing to develop a vaccine for COVID-19, it looks like the United States has secured almost all of the world’s supply of interim drug remdesivir to treat patients with COVID-19.

...

Potential COVID-19 vaccine by Bharat Biotech to enter clinical trials
Potential COVID-19 vaccine by Bharat Biotech to enter clinical trials
By Pankaj Singh

Bharat Biotech International, a leading Indian biotechnology company, has reportedly announced that its potential coronavirus vaccine, Covaxin, has received Drug Controller General of India (DCGI) approval to start hum...

Seattle Genetics reveals positive data from tisotumab vedotin trial
Seattle Genetics reveals positive data from tisotumab vedotin trial
By Pankaj Singh

Seattle Genetics, Inc., a renowned biotechnology firm that focuses on developing antibody-based cancer treatments, has recently revealed positive topline data from its Phase 2 clinical trial (innovaTV 204) assessing ti...